Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming, e-solutions company for clinical trials, eager to thrive on this development.
– Clinical trials must be adapted to this way of using information technology, says Saida El Maslouh.
But it is costly. Clinical trials are often the most expensive and challenging step for a small biotech company. The collection and handling of data is one of the main reasons why this is so costly. At Unithink’s presentation at the Biotech Forum, they will claim they can offer clinical data management at affordable prices even for very small biotech companies.
– Even a small biotech company can afford clinical e-solution nowadays. We have really shown that e-clinical solutions are affordable, says Saida El Maslouh.
She claims tha t data management and e-solutions have previously been too expensive and lacked a forecasting capability.
– That is why so many large pharma companies are in trouble today. We don’t only want to gather data, we aim to make knowledge of it for our sponsors, says Saida El Maslouh.
Unithink works with both sponsors and cro:s. Saida El Maslouh claims their competitors have been too focused on information technology and have lacked knowledge of the clinical field.
– That is not really what life science companies need, says El Maslouh.
The future market for clinical e-tools is a rough one, according to Saida El Maslouh. The market in Europe is growing while the US market has seen major e-tools players fighting each other.
– I have noticed that many of the top European managers are very careful when investing in e-tools. I guess they have not been pleased with what they have been purchasing before, says El Maslouh.
